Shapiro CL - Search Results

1

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Shulman LN, Berry DA, Cirrincione CT, Becker HP, Perez EA, O'Regan R, Martino S, Shapiro CL, Schneider CJ, Kimmick G, Burstein HJ, Norton L, Muss H, Hudis CA, Winer EP. Shulman LN, et al. Among authors: shapiro cl. J Clin Oncol. 2014 Aug 1;32(22):2311-7. doi: 10.1200/JCO.2013.53.7142. Epub 2014 Jun 16. J Clin Oncol. 2014. PMID: 24934787 Free PMC article. Clinical Trial.

2

Treatment of metastatic breast cancer: present and future prospects.

Hayes DF, Henderson IC, Shapiro CL. Hayes DF, et al. Among authors: shapiro cl. Semin Oncol. 1995 Apr;22(2 Suppl 5):5-19; discussion 19-21. Semin Oncol. 1995. PMID: 7537913 Review.

3

Adjuvant therapy of breast cancer.

Shapiro CL, Henderson IC. Shapiro CL, et al. Hematol Oncol Clin North Am. 1994 Feb;8(1):213-31. Hematol Oncol Clin North Am. 1994. PMID: 8150781 Review.

4

Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.

Shapiro CL, Gelman RS, Hayes DF, Osteen R, Obando A, Canellos GP, Frei E 3rd, Henderson IC. Shapiro CL, et al. J Natl Cancer Inst. 1993 May 19;85(10):812-7. doi: 10.1093/jnci/85.10.812. J Natl Cancer Inst. 1993. PMID: 8487326 Clinical Trial.

5

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.

Shapiro CL, Ayash L, Webb IJ, Gelman R, Keating J, Williams L, Demetri G, Clark P, Elias A, Duggan D, Hayes D, Hurd D, Henderson IC. Shapiro CL, et al. J Clin Oncol. 1997 Feb;15(2):674-83. doi: 10.1200/JCO.1997.15.2.674. J Clin Oncol. 1997. PMID: 9053493

6

Use of breast-conserving surgery for treatment of stage I and stage II breast cancer.

Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB. Guadagnoli E, et al. Among authors: shapiro cl. J Clin Oncol. 1998 Jan;16(1):101-6. doi: 10.1200/JCO.1998.16.1.101. J Clin Oncol. 1998. PMID: 9440729

7

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).

Costanza ME, Berry D, Henderson IC, Ratain MJ, Wu K, Shapiro C, Duggan D, Kalra J, Berkowitz I, Lyss AP. Costanza ME, et al. Clin Cancer Res. 1995 Jul;1(7):699-704. Clin Cancer Res. 1995. PMID: 9816035 Clinical Trial.

8

Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.

Shapiro CL, Hardenbergh PH, Gelman R, Blanks D, Hauptman P, Recht A, Hayes DF, Harris J, Henderson IC. Shapiro CL, et al. J Clin Oncol. 1998 Nov;16(11):3493-501. doi: 10.1200/JCO.1998.16.11.3493. J Clin Oncol. 1998. PMID: 9817266 Clinical Trial.

9

Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group.

Shapiro CL, Ervin T, Welles L, Azarnia N, Keating J, Hayes DF. Shapiro CL, et al. J Clin Oncol. 1999 May;17(5):1435-41. doi: 10.1200/JCO.1999.17.5.1435. J Clin Oncol. 1999. PMID: 10334528 Clinical Trial.

10

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.

Shapiro CL, Manola J, Leboff M. Shapiro CL, et al. J Clin Oncol. 2001 Jul 15;19(14):3306-11. doi: 10.1200/JCO.2001.19.14.3306. J Clin Oncol. 2001. PMID: 11454877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters